Objective Emergency physicians experience difficulty in determining the disposition of patients with elevated troponin I levels using emergency room tests. In this study, we aimed to investigate factors that could discriminate between the occurrence of type 1 myocardial infarction (T1MI) and type 2 myocardial infarction (T2MI) in patients with elevated troponin I levels.
Methods Patients admitted to the emergency department between January 1, 2017 and June 30, 2017 with elevated troponin I levels who underwent subsequent cardiac biomarker testing were included. Samples for baseline blood tests, such as cardiac biomarker levels, were collected within approximately 10 minutes of admission. Electrocardiogram, transthoracic echocardiography, and percutaneous coronary intervention results were retrospectively examined via patient report and chart reviews.
Results During the study period, 169 of 234 (72%) patients were diagnosed with T2MI and 65 (28%) were diagnosed with T1MI. Among various factors, typical chest pain (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.46 to 13.24; P=0.008), high troponin I levels (OR, 1.50; 95% CI, 1.19 to 1.90; P<0.001), high cholesterol (OR, 1.01; 95% CI, 1.00 to 1.02; P=0.008), and low D-dimer levels (OR, 0.87; 95% CI, 0.77 to 0.98; P=0.027) were significantly associated with T1MI incidence.
Conclusion Our findings in this study indicate that typical chest pain, high levels of troponin I and cholesterol, and low levels of D-dimer were associated with the diagnosis of T1MI. Further studies are suggested to determine the cut-off values for accurate diagnosis of T1MI in the ED.
Citations
Citations to this article as recorded by
Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review Pishoy Gouda, Shehzeen Lalani, Kristin Newby, Renato Lopes, Schuyler Jones Open Heart.2026; 13(1): e003867. CrossRef
Controversial issues of type 2 myocardial infarction patients management V. I. Kinash, A. S. Vorobev, I. A. Urvantseva, L. V. Kovalenko, V. V. Kashtalap Complex Issues of Cardiovascular Diseases.2022; 11(1): 78. CrossRef
Objective We aimed to compare the multi-marker strategy (copeptin and high-sensitivity cardiac troponin I [hs-cTnI]) with serial hs-cTnI measurements to rule out acute myocardial infarction (AMI) in patients with chest pain.
Methods This prospective observational study was performed in a single emergency department. To test the non-inferiority margin of 4% in terms of negative predictive value (NPV) between the multi-marker strategy (0 hour) and serial hs-cTnI measurements (0 and 2 hours), 262 participants were required. Samples for copeptin and hs-cTnI assays were collected at presentation (0 hour) and after 2 hours. The measured biomarkers were considered abnormal when hs-cTnI was >26.2 ng/L and when copeptin was >10 pmol/L.
Results AMI was diagnosed in 28 patients (10.7%). The NPV of the multi-marker strategy was 100% (160/160; 95% confidence interval [CI], 97.7% to 100%), which was not inferior to that of serial hs-cTnI measurements (201/201; 100%; 95% CI, 98.2% to 100%). The sensitivity, specificity, and positive predictive value of the multi-marker strategy were 100% (95% CI, 87.7% to 100%), 68.1% (95% CI, 61.7% to 74.0%), and 27.2% (95% CI, 18.9% to 36.8%), respectively. The sensitivity, specificity, and positive predictive value of serial hs-cTnI measurements were 100% (95% CI, 87.7% to 100%), 85.5% (95% CI, 80.4% to 89.8%), and 45.2% (95% CI, 32.5% to 58.3%), respectively.
Conclusion The multi-marker strategy (copeptin and hs-cTnI measurement) was not inferior to serial hs-cTnI measurements in terms of NPV for AMI diagnosis, with a sensitivity and NPV of 100%. Copeptin may help in the early rule-out of AMI in patients with chest pain.
Citations
Citations to this article as recorded by
The Incremental Value of Copeptin for the Early Rule-Out of Non-ST Elevation Myocardial Infarction in the Emergency Department Sofia Bezati, Christos Verras, Vasiliki Bistola, Dionysis Matsiras, Estela Kiouri, Lambros Markos, Ioannis Ventoulis, Effie Polyzogopoulou, John Parissis Journal of Clinical Medicine.2026; 15(9): 3251. CrossRef
Evaluation of Copeptin and High-Sensitivity Troponin I in Early Diagnosis of Acute Coronary Syndrome Suhaib Saber Asaad, Jassim Muhammed Ibrahim Kurdistan Journal of Applied Research.2026; 11(1): 181. CrossRef
Copeptin in Acute Myocardial Infarction: Is There a Role in the Era of High-Sensitivity Troponins? Sofia Bezati, Ioannis Ventoulis, Vasiliki Bistola, Christos Verras, Dionysis Matsiras, Effie Polyzogopoulou, John Parissis Journal of Cardiovascular Development and Disease.2025; 12(4): 144. CrossRef
ATUALIZAÇÃO SOBRE OS BIOMARCADORES PRECOCES DO INFARTO AGUDO DO MIOCÁRDIO E SUAS RELAÇÕES COM A TROPONINA CARDÍACA: UMA REVISÃO DE LITERATURA Paula Rayssa Rodrigues, Gabriel Santiago De Faria, Alessandra Cristina Pupin Silvério RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218.2024; 5(8): e585497. CrossRef
Copeptin plus troponin in the rapid rule out of acute myocardial infarction and prognostic value on post-myocardial infarction outcomes: a systematic review and diagnostic accuracy study Sheref A. Elseidy, Ahmed K. Awad, Debvarsha Mandal, Mounika Vorla, Ahmed Elkheshen, Tamam Mohamad Heart and Vessels.2023; 38(1): 1. CrossRef
Copeptin with high-sensitivity cardiac troponin to rule out non-ST-elevation myocardial infarction early on: A systematic review and meta-analysis Danni Mu, Jian Zhong, Lei Li, Jin Cheng, Yutong Zou, Ling Qiu, Xinqi Cheng Clinical Biochemistry.2023; 112: 24. CrossRef
Acute coronary syndrome as a current issue of pediatric cardiology. Outcomes and prognosis: Clinical case N. V. Tomchik, T. A. Lashkovskaya, A. I. Kizilevich, A. I. Matveichyk Kuban Scientific Medical Bulletin.2023; 30(5): 113. CrossRef
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases Danni Mu, Jin Cheng, Ling Qiu, Xinqi Cheng Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients Lukasz Szarpak, Marcin Lapinski, Aleksandra Gasecka, Michal Pruc, Wiktoria L. Drela, Mariusz Koda, Andrea Denegri, Frank W. Peacock, Miłosz J. Jaguszewski, Krzysztof J. Filipiak Journal of Cardiovascular Development and Disease.2021; 9(1): 6. CrossRef
Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis Hao Ling, Ziyuan Guo, Shuangshuang Du, Yinghong Liao, Yunyan Li, Chao Ding, Chunli Song Biomarkers.2020; 25(7): 539. CrossRef
Objective Adverse cardiovascular events (ACVEs) account for a large proportion of the morbidities and mortalities associated with drug overdose emergencies. However, there are no published reports regarding outcomes of ACVEs associated with acute dapsone poisoning. Here, the authors retrospectively analyzed ACVEs reported within 48 hours of treatment in patients with acute dapsone poisoning and assessed the significance of ACVEs as early predictors of mortality.
Methods Sixty-one consecutive cases of acute dapsone poisoning that were diagnosed and treated at a regional emergency center between 2006 and 2014 were included in the study. An ACVE was defined as myocardial injury, shock, ventricular dysrhythmia, cardiac arrest, or any combination of these occurring within the first 48 hours of treatment for acute dapsone poisoning.
Results Nineteen patients (31.1%) had evidence of myocardial injury (elevation of serum troponin-I level or electrocardiography signs of ischemia) after dapsone overdose, and there were a total of 19 ACVEs (31.1%), including one case of shock (1.6%). Fourteen patients (23.0%) died from pneumonia or multiple organ failure, and the incidence of ACVEs was significantly higher among non-survivors than among survivors (64.3% vs. 21.3%, P=0.006). ACVE was a significant predictor of mortality (odds ratio, 5.690; 95% confidence interval, 1.428 to 22.675; P=0.014).
Conclusion The incidence of ACVE was significantly higher among patients who died after acute dapsone poisoning. ACVE is a significant predictor of mortality after dapsone overdose, and evidence of ACVE should be carefully sought in these patients.
Citations
Citations to this article as recorded by
Bullous pemphigoid: Pathogenesis and therapeutic correlates Ryan S.Q. Geng, Siddhartha Sood, Jensen Yeung, Asfandyar Mufti JAAD Reviews.2026; 8: 137. CrossRef
Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature Giulia Gasparini, Roberto Russo, Laura Calabrese, Martina D’Onghia, Giovanni Di Zenzo, Dario Didona, Martina Merli, Pietro Quaglino, Roberto Maglie, Emiliano Antiga, Marzia Caproni, Clara De Simone, Luisa Boeti, Gianluca Avallone, Luca Valtellini, Angelo Dermatologic Therapy.2025;[Epub] CrossRef
Development of a risk-prediction nomogram for in-hospital adverse cardiovascular events in acute cardiotoxic agents poisoning Heba I. Lashin, Fatma M. Elgazzar, Sara I. El sharkawy, Sally M. Elsawaf, Zahraa Khalifa Sobh Toxicology Reports.2024; 13: 101826. CrossRef
Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits? Selami Aykut Temiz, Munise Daye Cutaneous and Ocular Toxicology.2022; 41(1): 60. CrossRef
Specific Treatment Exists for SARS-CoV-2 ARDS Badar Kanwar, Chul Joong Lee, Jong-Hoon Lee Vaccines.2021; 9(6): 635. CrossRef
The Neuroinflammasome in Alzheimer’s Disease and Cerebral Stroke Jong-hoon Lee, Chul Joong Lee, Jungwuk Park, So Jeong Lee, Su-hee Choi Dementia and Geriatric Cognitive Disorders Extra.2021; 11(2): 159. CrossRef
A Bitter Taste in Your Heart Conor J. Bloxham, Simon R. Foster, Walter G. Thomas Frontiers in Physiology.2020;[Epub] CrossRef
4,4′-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor Jong-hoon Lee, Ha Kyeu An, Mun-Gi Sohn, Paul Kivela, Sangsuk Oh International Journal of Molecular Sciences.2020; 21(17): 5953. CrossRef
The usefulness of the SOFA and APACHE II scoring systems for the early prediction of mortality in patients with dapsone poisoning Y Lee, SJ Kim, YS Kim, H Kim, DK Lee, J Lee, TH Go, YS Cha Human & Experimental Toxicology.2019; 38(3): 280. CrossRef
Analysis of Patients with Acute Toxic Exposure between 2009 and 2013: Data from the Korea Health Insurance Review and Assessment Service and the National Emergency Department Information System Young-Hoon Yoon, Jung-Youn Kim, Sung-Hyuk Choi Journal of Korean Medical Science.2018;[Epub] CrossRef
Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats Changwoo Kang, Dong Hoon Kim, Taeyun Kim, Soo Hoon Lee, Jin Hee Jeong, Sang Bong Lee, Jin Hyun Kim, Myeong Hee Jung, Kyung-woo Lee, In Sung Park Clinical and Experimental Emergency Medicine.2018; 5(3): 192. CrossRef
First
Prev
